HR
Howe & Rusling Portfolio holdings
AUM
$1.35B
This Quarter Return
+5.63%
1 Year Return
+20.22%
3 Year Return
+65.82%
5 Year Return
+120.71%
10 Year Return
+233.38%
AUM
$894M
AUM Growth
+$894M
(+6.5%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
28.23%
Holding
350
New
47
Increased
126
Reduced
110
Closed
18
Top Buys
| 1 |
Amphenol
APH
|
$7.31M |
| 2 |
Accenture
ACN
|
$5.07M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
$3.21M |
| 4 |
Genpact
G
|
$3.01M |
| 5 |
KLA
KLAC
|
$2.59M |
Top Sells
| 1 |
Oneok
OKE
|
$4.03M |
| 2 |
Johnson & Johnson
JNJ
|
$3.31M |
| 3 |
UnitedHealth
UNH
|
$2.17M |
| 4 |
Vanguard Russell 2000 ETF
VTWO
|
$1.86M |
| 5 |
Apple
AAPL
|
$1.69M |
Sector Composition
| 1 | Technology | 15.86% |
| 2 | Healthcare | 11.58% |
| 3 | Financials | 10.42% |
| 4 | Consumer Staples | 8.55% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Allstate
ALL
$53.9B
| $408K | 0.05% |
3,745
-1,146
| -23% | -$125K |
|
152
Murphy USA
MUSA
$7.16B
| $396K | 0.04% |
1,273
+77
| +6% | +$24K |
|
153
GE Aerospace
GE
$293B
| $390K | 0.04% |
4,453
-49
| -1% | -$4.3K |
|
154
US Physical Therapy
USPH
$1.27B
| $388K | 0.04% |
3,200
+877
| +38% | +$106K |
|
155
IBM
IBM
$227B
| $377K | 0.04% |
2,815
-125
| -4% | -$16.7K |
|
156
Northrop Grumman
NOC
$83.2B
| $373K | 0.04% |
818
+5
| +0.6% | +$2.28K |
|
|
SGEN
157
DELISTED
Seagen Inc. Common Stock
SGEN
| $368K | 0.04% |
1,914
-854
| -31% | -$164K |
|
158
Enerpac Tool Group
EPAC
$2.26B
| $365K | 0.04% |
13,524
| – | – |
|
159
United Parcel Service
UPS
$72.3B
| $363K | 0.04% |
2,028
+5
| +0.2% | +$896 |
|
160
Gilead Sciences
GILD
$140B
| $362K | 0.04% |
4,701
+102
| +2% | +$7.86K |
|
161
Sherwin-Williams
SHW
$90.5B
| $360K | 0.04% |
+1,356
| New | +$360K |
|
162
iShares Russell 2000 ETF
IWM
$66.6B
| $357K | 0.04% |
1,906
| – | – |
|
163
Brink's
BCO
$4.69B
| $356K | 0.04% |
5,249
| – | – |
|
164
WEC Energy
WEC
$34.4B
| $355K | 0.04% |
4,019
| – | – |
|
165
Timken Company
TKR
$5.23B
| $347K | 0.04% |
3,792
-458
| -11% | -$41.9K |
|
166
NBT Bancorp
NBTB
$2.3B
| $345K | 0.04% |
10,832
| – | – |
|
167
W.W. Grainger
GWW
$48.7B
| $335K | 0.04% |
425
| – | – |
|
168
First Trust Consumer Staples AlphaDEX Fund
FXG
$286M
| $331K | 0.04% |
5,282
-2,240
| -30% | -$140K |
|
169
Ingevity
NGVT
$2.11B
| $329K | 0.04% |
5,661
+947
| +20% | +$55.1K |
|
170
Schwab Fundamental US Large Company Index ETF
FNDX
$19.7B
| $329K | 0.04% |
17,145
-1,422
| -8% | -$27.3K |
|
171
Eli Lilly
LLY
$661B
| $328K | 0.04% |
699
-57
| -8% | -$26.7K |
|
172
Berkshire Hathaway Class B
BRK.B
$1.08T
| $326K | 0.04% |
957
| – | – |
|
173
MGP Ingredients
MGPI
$622M
| $326K | 0.04% |
3,063
| – | – |
|
174
ConocoPhillips
COP
$118B
| $317K | 0.04% |
3,061
-1,090
| -26% | -$113K |
|
175
Regeneron Pharmaceuticals
REGN
$59.8B
| $315K | 0.04% |
438
| – | – |
|